Abstract:
Treatment of Urinary Incontinence Associated with Pelvic
Floor Muscle Weakness
Sandra F. Reilley,
MD, FACOG. "Treatment of Urinary Incontinence Associated
with Pelvic Floor Muscle Weakness." Journal of
Pelvic Surgery 8 (May 2002) 3: 131-40.
Objectives:
To determine the effectiveness of behavioral therapy,
particularly biofeedback-assisted pelvic floor muscle
rehabilitation, in treating urinary incontinence.
Methods:
To determine their eligibility for behavioral therapy,
incontinent patients were evaluated by means of a medical
and incontinence history and a physical examination.
The evaluation included a review of medications and
social factors, a bladder and bowel diary, a neurologic
assessment, an abdominal exam, a thorough pelvic/rectal
exam, assessment of mobility, standard laboratory tests
such as urinalysis, and measurement of post-void residual
(PVR) using the BladderScan®
Bladder Volume Instrument.
Of the patients
who were evaluated, 270 entered pelvic floor muscle
rehabilitation and behavioral therapy (PFMR-BT). Stress
UI was the primary diagnosis in 41%, urge UI in 44%,
and mixed UI in the remaining 15%. The PFMR-BT program
used combined biofeedback-assisted PFM exercises, bladder
retraining, dietary modification, bladder emptying techniques,
a bowel regularity program, and coping strategies for
stress and urge.
Results:
70% of the patients who entered therapy completed the
program. The only difference between completers and
non-completers was in their cognitive ability to understand
the program and independent personal motivation.
76% of the
patients who completed the program were cured of UI,
15% were significantly improved, and 8% continued to
suffer moderate to severe incontinence. Follow-up evaluations
showed that after 2 years, patients continuing to exercise
daily maintained the improvements continence.
Conclusions:
When treated with pelvic floor muscle rehabilitation
and behavioral therapy, patients with UI related to
pelvic floor muscle weakness have a high cure rate (76%).
This method of therapy demonstrates both short and long-term
effectiveness. Furthermore, the patient prefers behavioral
therapy because it is noninvasive. Behavioral therapy
also has the fewest potential adverse complications
when compared to pharmacologic and surgical methods
of treatment. Reilley writes, "The first choice
of therapy should be the least invasive treatment with
the fewest potential adverse complications that is appropriate
for the patient." She advocates more widespread
use of PFMR-BT for patients whose incontinence is related
to pelvic floor muscle weakness.
If you would
like to read this study, please contact
us and we will send a copy to you.
|